Patent · US Active

Triazolo(4,5-D)pyrimidine compounds

USRE46276E1 · kind E1 · reissue

0Cited by
27References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 21, 2015
Grant dateJan 17, 2017
Priority date
Expiry dateDec 21, 2035

Classification

  • Technology area (CPC —)General

Abstract

Triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation. The compounds of the invention have the formula (I) as follows:wherein R, X and R1 through R3 are as defined in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.